PNEUMOCOCCAL DISEASE
Clinical trials for PNEUMOCOCCAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pneumonia vaccine trial aims to shield adults from serious infection
⭐️ VACCINE ⭐️ OngoingThis study tests a new pneumococcal vaccine in adults 18 and older to see if it is safe and triggers a strong immune response. The vaccine is designed to protect against pneumococcal disease, which can cause pneumonia and other serious infections. Participants receive one shot an…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 12:57 UTC
-
New infant vaccine trial aims to outsmart pneumonia germs
⭐️ VACCINE ⭐️ OngoingThis study tests a new pneumococcal vaccine (PG4) in healthy infants to see if it is safe and helps their bodies fight off germs that cause pneumonia and other infections. About 605 babies will receive either the new vaccine or a current one, with blood samples taken to measure p…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 12:54 UTC
-
New vaccine targets 20 pneumonia strains in chinese trial
⭐️ VACCINE ⭐️ OngoingThis early-stage study is testing a new vaccine that protects against 20 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. Around 200 healthy Chinese adults, children, and infants will receive the vaccine according to age-specific schedules. …
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
New vaccine safety check for infants in japan
⭐️ VACCINE ⭐️ OngoingThis study looks at how safe the PREVENAR 20 vaccine is for infants in Japan. About 1,100 babies aged 2 to 6 months will receive four doses of the vaccine. Researchers will track any side effects from the first shot until 28 days after the last shot.
Matched conditions: PNEUMOCOCCAL DISEASE
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:48 UTC